DREAM-HF trial results highlight Mesoblast’s potential to differentiate in HF space: GlobalData EP News Bureau Dec 19, 2024 Revascor shows potential in reducing cardiovascular mortality and improving outcomes in high-risk heart failure patients, marking…
